Table 4.
Medical Treatment | Key aimsa | Suggested choices or dose |
---|---|---|
Broad-spectrum topical antibiotics | Prophylaxis against infection in presence of epithelial defects. | Topical PF fluoroquinolones or chloramphenicol four times a day |
Potent steroid eye drops | Reduce inflammation and proteolytic enzyme release, preventing uveitis and stromal melting. | Topical PF dexamethasone 0.1% or prednisolone acetate 1%, 1–2 hourly |
Potassium ascorbate 10% eye drops | Co-factor for collagen synthesis (needed for corneal stromal healing), protecting against corneal ulceration and perforation | 1–2 hourly |
Oral ascorbic acid | As above | 1 g twice a day |
Sodium citrate 10.11% eye drops | Chelation of cations and preventing release of proteolytic enzymes, preventing corneal melts/perforation. | 1–2 hourly |
Oral tetracycline | Suppressing proteolytic enzymes and scavenging free oxygen radicals release. Halting corneal epithelial and stromal melts. | Doxycycline 100 mg once daily, or oxytetracycline 500 mg twice a day |
Cycloplegic eye drop | Mydriasis and pain relief | Topical PF cyclopentolate 1%, 2–3 times a day |
Lubricating eye drops (PF) | Prevents drying and promotes re-epithelialisation | Locally available PF eye drops, 1–2 hourly |
IOP lowering therapy | Control raised intraocular pressure | Treatment choice depends on level of ocular hypertension. Early consultation with glaucoma team advised. |
PF preservative-free
aSee references in respective sections below